Audion Therapeutics
PrivateLast Round
Grant
Sep 7, 2015
Total Funding Raised
$9.26M
Company Overview
Audion Therapeutics is a biopharmaceutical company that develops regenerative therapies for the treatment of sensorineural hearing loss.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Audion Therapeutics Comparables
Compare Audion Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Salubritas Therapeutics | 88% | |
| AudioCure Pharma | 86% | |
| Sound Pharmaceuticals, Inc. | 83% | |
Audion Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 7, 2015 | ||||
| Series B | Sep 7, 2015 | ||||
| Series A | Feb 10, 2014 |
Audion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Inkef Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 10, 2014
Eli Lilly and Company led the Series A round.
Audion Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Audion Therapeutics's valuation, stock price, and market status.